The KLC Law Firm has advised Teva on the divestment of its Greek manufacturing site to PharmaPath.
Teva Pharmaceuticals develops and produces generic and specialty medicines with a portfolio of 3,500 products.
Founded in 2017, PharmaPath is a European pharmaceutical company located in Greece. The company specializes in the in-house development, registration, manufacturing, supply, and life-cycle management of pharmaceutical products.
KLC did not provide further information on the deal.
